Skip to content
10-K

Annual Report

NeuroOne Medical Technologies Corporation NMTC

0001213900-25-122390

← back to feed
Filed
Dec 17, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Dec 12, 2025 50.41M sh
Shares Diluted FY 2025 · Sep 30, 2025 40.15M sh
Shares Diluted FY 2025 · Sep 30, 2024 26.76M sh
Capex FY 2025 · Sep 30, 2025 $81.74K
Capex FY 2025 · Sep 30, 2024 $120.2K
Operating Cash Flow FY 2025 · Sep 30, 2025 −$2.84M
Operating Cash Flow FY 2025 · Sep 30, 2024 −$11.01M
Cash And Equivalents FY 2025 · Sep 30, 2025 $6.57M
Cash And Equivalents FY 2025 · Sep 30, 2024 $1.46M
Stockholders Equity FY 2025 · Sep 30, 2025 $7.07M
Stockholders Equity FY 2025 · Sep 30, 2024 $822.01K
Stockholders Equity FY 2025 · Sep 30, 2023 $6.25M
Current Liabilities FY 2025 · Sep 30, 2025 $2.3M
Current Liabilities FY 2025 · Sep 30, 2024 $2.21M
Total Liabilities FY 2025 · Sep 30, 2025 $3.71M
Total Liabilities FY 2025 · Sep 30, 2024 $4.55M
Current Assets FY 2025 · Sep 30, 2025 $10.23M
Current Assets FY 2025 · Sep 30, 2024 $4.63M
Total Assets FY 2025 · Sep 30, 2025 $10.79M
Total Assets FY 2025 · Sep 30, 2024 $5.37M
Eps Diluted FY 2025 · Sep 30, 2025 −$0.09
Eps Diluted FY 2025 · Sep 30, 2024 −$0.46
Eps Basic FY 2025 · Sep 30, 2025 −$0.09
Eps Basic FY 2025 · Sep 30, 2024 −$0.46
Sga Expense FY 2025 · Sep 30, 2025 $7.38M
Sga Expense FY 2025 · Sep 30, 2024 $7.9M
Rd Expense FY 2025 · Sep 30, 2025 $4.98M
Rd Expense FY 2025 · Sep 30, 2024 $5.07M
Net Income FY 2025 · Sep 30, 2025 −$3.61M
Net Income FY 2025 · Sep 30, 2024 −$12.32M
Operating Income FY 2025 · Sep 30, 2025 −$4.23M
Operating Income FY 2025 · Sep 30, 2024 −$11.89M
Gross Profit FY 2025 · Sep 30, 2025 $5.14M
Gross Profit FY 2025 · Sep 30, 2024 $1.08M
Cost Of Revenue FY 2025 · Sep 30, 2025 $3.96M
Cost Of Revenue FY 2025 · Sep 30, 2024 $2.37M
Revenue FY 2025 · Sep 30, 2025 $9.1M
Revenue FY 2025 · Sep 30, 2024 $3.45M